Search Results for

*

1-10 of 10 ResultsHelp using search on aafp.org Sort by Relevance , Date , Title

Cytochrome P450: New Nomenclature and Clinical Implications - American Family Physician

Jan 1, 1998 - Many drug interactions are a result of inhibition or induction of cytochrome P450 enzymes (CYP450). The CYP3A subfamily is involved in many clinically significant drug interactions, including those involving nonsedating antihistamines and cisapride, that may result in cardiac ...

American Family Physician : Article

https://www.aafp.org/afp/1998/0101/p107.html

Inborn Errors of Metabolism in Infancy and Early Childhood: An Update - American Family...

Jun 1, 2006 - Recent innovations in medical technology have changed newborn screening programs in the United States. The widespread use of tandem mass spectrometry is helping to identify more inborn errors of metabolism. Primary care physicians often are the first to be contacted by state and ...

American Family Physician : Article

https://www.aafp.org/afp/2006/0601/p1981.html

Opportunities to Improve Outcomes in Sickle Cell Disease - American Family Physician

Jul 15, 2006 - Sickle cell disease represents a spectrum of inherited hemoglobin disorders. The pathophysiology involves abnormalities not just in red blood cells but also vascular endothelium, white blood cell function, coagulation, and inflammatory response. Known sequelae of sickle cell disease ...

American Family Physician : Article

https://www.aafp.org/afp/2006/0715/p303.html

Pharmacogenentics: Using DNA to Optimize Drug Therapy - American Family Physician

Oct 15, 2007 - Pharmacogenetics is a growing field of research that focuses on the interaction between genetics and drug therapy. Relationships between genetic variation and drug effect have been observed for a growing number of commonly used drugs. Validation studies may soon define the use of these ...

American Family Physician : Article

https://www.aafp.org/afp/2007/1015/p1179.html

Pharmacogenetic Testing—An Unfulfilled Promise - Editorials - American Family Physician

Oct 1, 2015 - Family physicians should not naively accept a new technology because it is the latest trend. We need to assess the clinical utility of potential applications of genetic information, adopting them when they improve patient-oriented outcomes and avoiding them when they simply add costs ...

American Family Physician : Editorials

https://www.aafp.org/afp/2015/1001/p558.html

Pharmacogenetics: Using Genetic Information to Guide Drug Therapy - American Family ...

Oct 1, 2015 - Clinical pharmacogenetics, the use of genetic data to guide drug therapy decisions, is beginning to be used for medications commonly prescribed by family physicians. However, clinicians are largely unfamiliar with principles supporting clinical use of this type of data. For example, ...

American Family Physician : Article

https://www.aafp.org/afp/2015/1001/p588.html

Practice Guidelines - Apr 15, 2006 - American Family Physician

Apr 15, 2006 - The American College of Obstetricians and Gynecologists (ACOG) has released recommendations for screening for Tay-Sachs disease.

American Family Physician : Practice Guidelines

https://www.aafp.org/afp/2006/0415/p1471a.html

Practice Guidelines - Apr 15, 2006 - American Family Physician

Apr 15, 2006 - The American College of Obstetricians and Gynecologists (ACOG) has released an opinion statement on issues specific to pregnancy in obese women. Women who are obese are at increased risk of complications of pregnancy such as gestational hypertension and diabetes, preeclampsia, fetal ...

American Family Physician : Practice Guidelines

https://www.aafp.org/afp/2006/0415/p1471.html

Role of the Family Physician in the Management of Cystic Fibrosis - Editorials - ...

Jun 15, 2015 - Advertisement << Previous article Next article >> Jun 15, 2015 Issue Editorials Role of the Family Physician in the Management of Cystic Fibrosis DOUGLAS LEWIS, MD, Via Christi Family Medicine Residency, Via Christi Adult Cystic Fibrosis Specialty Clinic, Wichita, Kansas Am Fam...

American Family Physician : Editorials

https://www.aafp.org/afp/2015/0615/p822.html

The Effect of Cytochrome P450 Metabolism on Drug Response, Interactions, and Adverse ...

Aug 1, 2007 - Cytochrome P450 enzymes are essential for the metabolism of many medications. Although this class has more than 50 enzymes, six of them metabolize 90 percent of drugs, with the two most significant enzymes being CYP3A4 and CYP2D6. Genetic variability (polymorphism) in these enzymes may ...

American Family Physician : Article

https://www.aafp.org/afp/2007/0801/p391.html

Page  1

25 50 100 results per page